How did TG Therapeutics' revenue surge in Q3 2023 compared to previous quarters?

Tg Therapeutics' revenue surged in Q3 2023 compared to previous quarters due to the significant increase in total revenue, which was $165.82 million for Q3 2023. This is a substantial increase from the previous quarter, Q2 2023, where the revenue was $16.07 million, and the quarter before that, Q1 2023, where the revenue was $7.8 million. The year-over-year growth rate for Q3 2023 was also impressive, with a reported growth of 1762.99% compared to the same period in the previous year. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |TGTX|TGTX.O|Tg Therapeutics|2022 Q4|-96.553209823352|80000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q1|287.05357142857144|7803000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q2|2606.060606060606|1.6074E7|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q3|176298.93617021275|1.65815E8|186| |code|Ticker|Name|Date|Total Revenue YoY|market_code| |---|---|---|---|---|---| |TGTX|TGTX.O|Tg Therapeutics|2022 Q4|-96.553209823352|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q1|287.05357142857144|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q2|2606.060606060606|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q3|176298.93617021275|186| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |TGTX|TGTX.O|Tg Therapeutics|2022 Q3|-95.36945812807882|94000|186| |TGTX|TGTX.O|Tg Therapeutics|2022 Q4|-96.553209823352|80000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q1|287.05357142857144|7803000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q2|2606.060606060606|1.6074E7|186| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |TGTX|TGTX.O|Tg Therapeutics|2022 Q2|-61.55339805825243|594000|186| |TGTX|TGTX.O|Tg Therapeutics|2022 Q3|-95.36945812807882|94000|186| |TGTX|TGTX.O|Tg Therapeutics|2022 Q4|-96.553209823352|80000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q1|287.05357142857144|7803000|186| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |TGTX|TGTX.O|Tg Therapeutics|2023 Q1|287.05357142857144|7803000|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q2|2606.060606060606|1.6074E7|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q3|176298.93617021275|1.65815E8|186| |TGTX|TGTX.O|Tg Therapeutics|2023 Q4|54863.75000000001|4.3971E7|186|